Cas:75676-72-1 2-Chloro-4-iodo-1-methoxybenzene manufacturer & supplier

We serve Chemical Name:2-Chloro-4-iodo-1-methoxybenzene CAS:75676-72-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Chloro-4-iodo-1-methoxybenzene

Chemical Name:2-Chloro-4-iodo-1-methoxybenzene
CAS.NO:75676-72-1
Synonyms:2-Chlor-4-jod-anisol;Benzene, 2-chloro-4-iodo-1-methoxy-;2-Chlor-4-jod-1-methoxy-benzol;2-Chloro-4-iodo-1-methoxybenzene;Benzene,2-chloro-4-iodo-1-methoxy;3-chloro-4-methoxyphenyl iodide;2-Chloro-4-iodoanisole
Molecular Formula:C7H6ClIO
Molecular Weight:268.479
HS Code:2909309090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:266.0±25.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.604
PSA:9.23000
Exact Mass:267.915192
LogP:3.48

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Chlor-4-jod-anisol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-4-iodoanisole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene,2-chloro-4-iodo-1-methoxy Use and application,2-Chloro-4-iodoanisole technical grade,usp/ep/jp grade.


Related News: Founded outside Venice in 1949 as a maker of glass bottles for wine and perfume, the firm shifted to glass packaging for the pharmaceutical sector in the early 1970s and later grew to become a leading player in the industry, expanding overseas with new factories in Mexico in 2007 and China in 2012. propyl 3,5-dibromo-4-[[2-(butylamino)acetyl]amino]benzoate manufacturers As a global-risk medical practice transforming care of the neediest populations, our centers are located in underserved neighborhoods,” notes Faisel Syed, M.D., ChenMed National Director of Primary Care. N-[4-(Benzothiazol-2-ylmethoxy)-2-methylphenyl]-N-methoxycarbonylbenzamide suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. 3-Deuterio-propylenoxyd vendor & factory.